12.00-13.00
Webinar
Part of a series of seminars featuring selected industry speakers, this time including Dr Bill Haynes of Novo Nordisk.
Topic: A multi-omics approach for type 2 diabetes target discovery: identification and characterisation of disease-specific small open reading frame encoded peptides.
Sponsored by the University of Oxford BioEscalator.
Further information and booking details here.